VKTX – Viking Therapeutics, Inc.
Viking Therapeutics, Inc.VKTX
$23.94Name : Viking Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $2,688,198,656.00
EPSttm : -1.01
Viking Therapeutics, Inc.
$23.94
1.44%$0.34Float Short %
23.51
Margin Of Safety %
Put/Call OI Ratio
0.25
EPS Next Q Diff
-0.04
EPS Last/This Y
-0.52
EPS This/Next Y
-0.54
Price
23.94
Target Price
95.44
Analyst Recom
1.22
Performance Q
-26.47
Relative Volume
1.07
Beta
0.79
Ticker: VKTX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-21 | VKTX | 28.92 | 0.29 | 0.43 | 203797 |
| 2025-03-24 | VKTX | 29.3 | 0.29 | 0.19 | 160326 |
| 2025-03-25 | VKTX | 27.99 | 0.28 | 0.14 | 170593 |
| 2025-03-26 | VKTX | 26.34 | 0.28 | 0.18 | 177529 |
| 2025-03-27 | VKTX | 26.13 | 0.27 | 0.11 | 193975 |
| 2025-03-28 | VKTX | 25.63 | 0.27 | 0.25 | 197873 |
| 2025-03-31 | VKTX | 24.14 | 0.27 | 0.08 | 194576 |
| 2025-04-01 | VKTX | 23.71 | 0.27 | 0.12 | 199685 |
| 2025-04-02 | VKTX | 25.69 | 0.27 | 0.15 | 200797 |
| 2025-04-03 | VKTX | 24.1 | 0.26 | 0.24 | 208928 |
| 2025-04-04 | VKTX | 22.61 | 0.26 | 0.48 | 210306 |
| 2025-04-07 | VKTX | 21.26 | 0.26 | 0.27 | 204214 |
| 2025-04-08 | VKTX | 19.99 | 0.26 | 0.22 | 206808 |
| 2025-04-09 | VKTX | 23.08 | 0.26 | 0.23 | 207824 |
| 2025-04-10 | VKTX | 21.52 | 0.25 | 0.25 | 210131 |
| 2025-04-11 | VKTX | 22.21 | 0.25 | 0.14 | 210865 |
| 2025-04-14 | VKTX | 24.52 | 0.26 | 0.06 | 200979 |
| 2025-04-15 | VKTX | 23.1 | 0.25 | 0.75 | 209191 |
| 2025-04-16 | VKTX | 23.58 | 0.25 | 0.09 | 216619 |
| 2025-04-17 | VKTX | 23.89 | 0.25 | 0.12 | 222745 |
| 2025-04-18 | VKTX | 23.94 | 0.25 | 0.12 | 222745 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-21 | VKTX | 28.92 | -21.9 | -58.4 | -1.55 |
| 2025-03-24 | VKTX | 29.28 | -21.9 | -56.1 | -1.55 |
| 2025-03-25 | VKTX | 27.98 | -21.9 | -40.2 | -1.55 |
| 2025-03-26 | VKTX | 26.34 | -21.9 | -35.9 | -1.55 |
| 2025-03-27 | VKTX | 26.11 | -21.9 | -50.1 | -1.55 |
| 2025-03-28 | VKTX | 25.65 | -21.9 | -47.3 | -1.55 |
| 2025-03-31 | VKTX | 24.15 | -21.9 | -35.4 | -1.55 |
| 2025-04-01 | VKTX | 23.91 | -21.9 | -50.0 | -1.55 |
| 2025-04-02 | VKTX | 25.68 | -21.9 | -75.3 | -1.55 |
| 2025-04-03 | VKTX | 24.22 | -21.9 | -35.8 | -1.55 |
| 2025-04-04 | VKTX | 22.62 | -21.9 | -32.6 | -1.55 |
| 2025-04-07 | VKTX | 21.24 | -21.9 | -33.5 | -1.55 |
| 2025-04-08 | VKTX | 19.98 | -21.9 | -33.0 | -1.55 |
| 2025-04-09 | VKTX | 23.10 | -21.9 | -106.5 | -1.55 |
| 2025-04-10 | VKTX | 21.52 | -19.7 | -31.8 | -1.53 |
| 2025-04-11 | VKTX | 22.21 | -19.7 | -62.9 | -1.53 |
| 2025-04-14 | VKTX | 24.57 | -19.7 | -86.5 | -1.53 |
| 2025-04-15 | VKTX | 23.11 | -19.7 | -34.7 | -1.53 |
| 2025-04-16 | VKTX | 23.62 | -19.7 | -59.5 | -1.53 |
| 2025-04-17 | VKTX | 23.94 | -19.7 | -57.2 | -1.53 |
| 2025-04-18 | VKTX | 23.94 | -19.7 | -52.7 | -1.53 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-21 | VKTX | -12.23 | 0.44 | 21.95 |
| 2025-03-24 | VKTX | -12.23 | 0.46 | 21.95 |
| 2025-03-25 | VKTX | -12.23 | 0.46 | 21.95 |
| 2025-03-26 | VKTX | -12.23 | 0.46 | 22.23 |
| 2025-03-27 | VKTX | -12.23 | 0.46 | 22.23 |
| 2025-03-28 | VKTX | -12.23 | 0.46 | 22.23 |
| 2025-03-31 | VKTX | -12.23 | 0.44 | 22.23 |
| 2025-04-01 | VKTX | -12.23 | 0.44 | 22.23 |
| 2025-04-02 | VKTX | -12.23 | 0.44 | 22.23 |
| 2025-04-03 | VKTX | -12.20 | 0.44 | 22.23 |
| 2025-04-04 | VKTX | -12.20 | 0.44 | 22.23 |
| 2025-04-07 | VKTX | -12.20 | 0.46 | 22.23 |
| 2025-04-08 | VKTX | -12.20 | 0.46 | 22.23 |
| 2025-04-09 | VKTX | -12.20 | 0.46 | 22.23 |
| 2025-04-10 | VKTX | -12.20 | 0.46 | 23.51 |
| 2025-04-11 | VKTX | -12.20 | 0.46 | 23.51 |
| 2025-04-14 | VKTX | -12.20 | 0.46 | 23.51 |
| 2025-04-15 | VKTX | -12.20 | 0.46 | 23.51 |
| 2025-04-16 | VKTX | -12.19 | 0.46 | 23.51 |
| 2025-04-17 | VKTX | -12.19 | 0.46 | 23.51 |
| 2025-04-18 | VKTX | -12.19 | 0.46 | 23.51 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.32
Avg. EPS Est. Current Quarter
-0.32
Avg. EPS Est. Next Quarter
-0.36
Insider Transactions
-12.19
Institutional Transactions
0.46
Beta
0.79
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
12
Growth Score
25
Sentiment Score
65
Actual DrawDown %
75.9
Max Drawdown 5-Year %
-78.9
Target Price
95.44
P/E
Forward P/E
PEG
P/S
P/B
3.03
P/Free Cash Flow
EPS
-1.01
Average EPS Est. Cur. Y
-1.53
EPS Next Y. (Est.)
-2.07
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.07
Return on Equity vs Sector %
-32.5
Return on Equity vs Industry %
-19.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
-52.7
Viking Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 36
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
stock quote shares VKTX – Viking Therapeutics, Inc. Stock Price stock today
news today VKTX – Viking Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics, Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics, Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading